deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02090244

Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?

Förbättrar PTH Postero-lateral fusionsläkning Vid Ryggkirurgi?

Sponsor: Medical Research Council of Southeast Sweden

Interventions Teriparatide
Updated 7 times since 2017 Last updated: Apr 16, 2019 Started: Aug 31, 2012 Primary completion: May 31, 2018 Completion: Jan 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Spinal Stenosis and is currently completed. Medical Research Council of Southeast Sweden leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotUnknown Status~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~May 2019 · 11 months · monthly snapshotActive Not Recruiting~May 2019 – ~Jan 2021 · 20 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. May 2019 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Active Not RecruitingCompleted

  5. Jun 2018 — May 2019 [monthly]

    Active Not Recruiting PHASE4

Show 2 earlier versions
  1. Oct 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE4

    Status: Unknown StatusActive Not Recruiting

  2. Jan 2017 — Oct 2017 [monthly]

    Unknown Status PHASE4

    First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical Research Council of Southeast Sweden
  • University Hospital, Linkoeping
Data source: University Hospital, Linkoeping

For direct contact, visit the study record on ClinicalTrials.gov .